Search Within

Dara Stacy Ross

Formats
  1. Meeting Abstract (86)
  2. Journal Article (57)
  3. Review (4)
  4. Book Section (2)
Groups
  1. Department of Pathology and Laboratory Medicine (149)
  2. GSK Faculty (76)
  3. Solid Tumor Oncology Division (69)
  4. Department of Medicine (68)
  5. Human Oncology and Pathogenesis Program (61)
  6. Breast Medicine Service (55)

More Groups

People
  1. Edi Brogi (69)
  2. Hannah Wen (50)
  3. Fresia Pareja Zea (36)
  4. Marc Ladanyi (36)
  5. Britta Weigelt (34)
  6. Pedram Razavi (33)

More People

Years
  1. 2025 (13)
  2. 2024 (21)
  3. 2023 (11)
  4. 2022 (15)
  5. 2021 (11)
  6. 2020 (17)

More Years

Publications
  1. Laboratory Investigation (40)
  2. Modern Pathology (31)
  3. Journal of Molecular Diagnostics (8)
  4. Journal of Clinical Oncology (6)
  5. Cancer Research (5)
  6. Archives of Pathology & Laboratory Medicine (4)

More Publications

Publishers
  1. Nature Publishing Group (47)
  2. Nature Research (31)
  3. Elsevier Science, Inc. (8)
  4. Oxford University Press (8)
  5. Springer (8)
  6. American Society of Clinical Oncology (6)

More Publishers

Results (149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio < 2, HER2 copy number ≥ 4 and < 6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Triple-positive breast carcinoma: A histopathologic and clinical study of patients treated with neoadjuvant chemotherapy
    Meeting Abstract

    Zeng, J.; Edelweiss, M.; Ross, D.; Moo, T. A.; Brogi, E.; D'Alfonso, T.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management
    Meeting Abstract

    Gupta, S.; Cheville, J.; Jungbluth, A.; Zhang, Y.; Zhang, L.; Chen, Y. B.; Tickoo, S.; Fine, S.; Gopalan, A.; Al-Ahmadie, H.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Automatic quantification of HER2 amplification in invasive breast cancer using chromogenic in situ hybridization (CISH) and computational pathology
    Meeting Abstract

    Hossain, M. S.; Nakamura, T.; Hanna, M.; Uraoka, N.; Ross, D. S.; Hameed, M. R.; Yamaguchi, M.; Yagi, Y.
    Virchows Archiv (2019)

    Fulltext@MSK | Save
  • JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: Implications for clinical management
    Journal Article

    Gupta, S.; Cheville, J. C.; Jungbluth, A. A.; Zhang, Y.; Zhang, L.; Chen, Y. B.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Al-Ahmadie, H. A.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio <2, HER2 copy number ≥ 4 and <6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Triple-positive breast carcinoma: A histopathologic and clinical study of patients treated with neoadjuvant chemotherapy
    Meeting Abstract

    Zeng, J.; Edelweiss, M.; Ross, D.; Moo, T. A.; Brogi, E.; D'Alfonso, T.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management
    Meeting Abstract

    Gupta, S.; Cheville, J.; Jungbluth, A.; Zhang, Y.; Zhang, L.; Chen, Y. B.; Tickoo, S.; Fine, S.; Gopalan, A.; Al-Ahmadie, H.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save